Surgical and Advanced Medical Therapy for the Treatment of Type 2 Diabetes in Class I Obese Patients: a Short-Term Outcome
Sign Up to like & getrecommendations! Published in 2017 at "Obesity Surgery"
DOI: 10.1007/s11695-017-2770-y
Abstract: BackgroundBariatric surgery, incretin-based therapy (glucagon-like peptide-1 analogues), and sodium-glucose co-transporter 2 (SGLT2) inhibitors have antidiabetic properties in morbidly obese patients. However, their comparative efficacy in treating type 2 diabetes mellitus (T2DM) in class I obese… read more here.
Keywords: class obese; treatment; obese patients; type diabetes ... See more keywords
Diabetes Resolution at 10 Years After Biliopancreatic Diversion in Overweight and Class 1 Obese Patients with Type 2 Diabetes
Sign Up to like & getrecommendations! Published in 2022 at "Obesity Surgery"
DOI: 10.1007/s11695-021-05870-4
Abstract: Long-term anti-diabetic effects of BPD in overweight or class 1 obese T2DM patients were investigated reporting the results at 10 years after BPD performed in severely non-obese T2DM patients. Thirty T2DM patients with BMI lower… read more here.
Keywords: class obese; t2dm patients; class; diabetes resolution ... See more keywords
Assessment of the diagnostic performance of the 1 mg dexamethasone suppression test in class 3 obese patients
Sign Up to like & getrecommendations! Published in 2022 at "Endocrine Regulations"
DOI: 10.2478/enr-2022-0028
Abstract: Abstract Objective. This study was aimed to evaluate the prevalence of Cushing’s syndrome and the diagnostic performance of the 1 mg dexamethasone suppression test in class 3 obese patients. Methods. Anthropometric measurements and other laboratory… read more here.
Keywords: dexamethasone suppression; suppression test; class obese;